FOXP3 and melanoma: High FoxP3+ Tregs was associated with worse OS in cervical, renal cell carcinoma (RCC), melanoma, HCC, gastric and breast cancers and an improved OS in CRC, head and neck cancer (HNC), and oesophageal cancer whereas the DFS rate was lower in lung cancer [156].